Artículos del autor

solaci

Day 2

COMPARE: Losartan shows promising results in patients with Marfan syndrome

Patients with Marfan syndrome (connective tissue disorder) are more susceptible to aortic dilation and consequently dissection and...
solaci -
Day 2

EXAMINE: The alogliptin is safe for treating type 2 diabetes in patients with a recent history of acute coronary syndrome.

Type 2 diabetes is associated both microvascular and macrovascular disease. Adequate glycemic control can reduce the risk...
solaci -
SOLACI

2nd-generation drug-eluting stents, results for “real” patients at two years

Original title: Clinical Outcome Following Stringent Discontinuation of Dual Anti-Platelet Therapy After 12 Months in Real-World Patients Treated...
solaci -
Institutional News

SOLACI lamenta el fallecimiento de la Dra. Liliana Grinfeld

La Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI) lamenta comunicar que en el día de la fecha ha...
solaci -
Institutional News

Cooperation Agreement SOLACI-CRF/TCT

On April 12, a five year cooperation agreement was signed in Sao Paulo (Brazil) between SOLACI and...
solaci -
Institutional News

SOLACI attended Cardio Interv 2014

SOLACI thanks the Costantino Costantini Foundation of Curitiba City, Brazil and its director Dr. Costantino Costantini, for...
solaci -
Institutional News

SOLACI relaunches its SOLidario program in Colombia

  The Latin American Society of Interventional Cardiology successfully relaunched its SOLidario program, practicing the implantation of an...
solaci -
Institutional News

Death of Miguel Granja MD

The Latin American Society of Interventional Cardiology (SOLACI) regrets to inform the deceased of Miguel Granja MD,...
solaci -